27 Sep Half year 2021 results
Solid underlying financial performance and well-positioned for continued growth
Paris, France and Camberley, UK – 27 September 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results for the half year ended 30 June 2021.
https://novacyt.com/wp-content/uploads/2021/09/Novacyt-H1-results-final-.pdf